Instil Bio (TIL) Shares Outstanding (2020 - 2026)
Instil Bio (TIL) posted quarterly Shares Outstanding (Entity) of $6.8 million for Q1 2026, up 3.4% year-over-year from $6.6 million in Q1 2025, and little changed quarter-over-quarter from $6.8 million in Q4 2025.
Instil Bio (TIL) Shares Outstanding (2020 - 2026) Analysis & Trends
Instil Bio's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 3.4% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $6.8 million (up 3.4% YoY), while the FY2025 annual figure was $6.8 million, up 3.92% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $6.8 million, roughly flat from $6.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $6.8 million in Q3 2025, with the low at $6.5 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $6.5 million (2022), against an average of $6.6 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) soared 269.44% in 2022, then dropped 0.0% in 2023.
- Instil Bio's Shares Outstanding (Entity) stood at $6.5 million in 2022, then slipped by 0.0% to $6.5 million in 2023, then climbed by 0.34% to $6.5 million in 2024, then increased by 3.92% to $6.8 million in 2025, then changed by 0.0% to $6.8 million in 2026.
- Business Quant data shows TIL's Shares Outstanding (Entity) at $6.8 million in Q1 2026, $6.8 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 445.06 Mn |
| 10 | Instil Bio | 51.14 Mn | 51.14 Mn | - | 6.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.78 Mn |
| Mar 31, 2026 | 6.78 Mn |
| Dec 31, 2025 | 6.67 Mn |
| Sep 30, 2025 | 6.76 Mn |
| Jun 30, 2025 | 6.60 Mn |
| Mar 31, 2025 | 6.53 Mn |
| Dec 31, 2024 | 6.51 Mn |
| Sep 30, 2024 | 6.51 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 6.50 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Sep 30, 2023 | 6.50 Mn |
| Jun 30, 2023 | 6.50 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 6.48 Mn |
| Sep 30, 2022 | 6.48 Mn |
| Jun 30, 2022 | 6.47 Mn |
| Mar 31, 2022 | 6.46 Mn |
| Dec 31, 2021 | 5.30 Mn |
| Sep 30, 2021 | 6.44 Mn |